drugset / Trial / NCT00527514

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

NCT00527514

Phase 3 Completed 185 enrolled Daiichi Sankyo
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will be conducted to assess the efficacy and safety of an amlodipine/olmesartan treatment regimen in stage 1 and stage 2 hypertensive subjects.

Timeline

Start
2007-09
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Olmesartan medoxomil Unknown

Indications